Clinical trial
Use of Cysteamine in the Treatment of Cystinosis
NCT00359684 · National Human Genome Research Institute (NHGRI), NIH · Recruiting
Key facts
| NCT number | NCT00359684 |
|---|---|
| Title | Use of Cysteamine in the Treatment of Cystinosis |
| Official title | Use of Cysteamine in the Treatment of Cystinosis |
| Lead sponsor | National Human Genome Research Institute (NHGRI), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Cystinosis |
| Intervention type | Drug |
| Interventions | Cysteamine |
| Enrollment | 330 |
| Start date | Jan 4, 1979 |
| First posted | Aug 2, 2006 |
| Last update posted | Jan 8, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: